Careers

Interested in joining our team? Visit our Careers page.

Blog

Company

About Us

Development

Licensing & Pipeline

Clinical Trials

Policies & Statements

Code of Conduct

Privacy Policy

Footer Menu

Our Model

Technology

For Patients

For Investigators

For Physicians

Pressroom & News

Press

Header Navigation

How Formation Bio is designing a resilient research engine using durable execution

Building Durable AI Workflows for Indication Landscaping

How Formation Bio uses Pareto frontiers to analyze the high-water marks for drug development

Where Drugs Win or Lose: Mapping the Competitive Bar in Biopharma with AI

How Formation Bio designs systems for sublinear scaling and compounding memory

Building an AI-Native Pharma Company

How Formation Bio built a human-in-the-loop pipeline to make genetic insights operational at scale

Scaling the Impact of Genetics Insights

How we built ARK – an MCP gateway that connects models, tools, and permissions to enable the next generation of AI-powered work at Formation Bio

ARK: A Gateway for AI-Native Work

How LLM-assisted processing transformed 260,000 unstructured clinical trials into 6.5 million structured components and embeddings

Structuring Clinical Trial Data at Scale

How Formation looks for “dark assets”– silently deprioritized candidates that may reveal hidden opportunity

Searching Across Silence

 of this series, we explored the architecture behind 

, our GenAI-powered recruitment tool that streamlines patient recruitment for clinical trials. In this post, we’ll take a deeper look at the execution layer that powers Muse’s assistants.

Introducing Muse

The Technical Architecture Powering Our AI Recruitment Tool Muse 

Deep Dive into the AI Features and Technical Implementation of Muse

In this post, we’ll explore the high-level architecture and key components that power Muse, offering a behind-the-scenes look at how we leverage OpenAI’s LLMs to create an efficient and effective tool for crafting recruitment strategies and content.

We envision a future where drug development is faster, more cost-effective, and significantly more likely to succeed, ultimately allowing us to achieve that mission - and AI is a key part of that vision.

Formation Bio's AI Vision Statement

We are excited about AI’s potential to meaningfully address the drug development bottleneck. We have begun incorporating LLMs and AI models in everything we do, and our plans for AI innovation and investment span short, medium, and long term horizons.

Our Vision for AI in Pharma

The Formation Values Interview (FVI) is a distinctive component of the hiring process at Formation Bio, focused on evaluating candidates' alignment with our

Navigating the Formation Values Interview

As we advance on our journey toward building the pharma company of the future, TrialSpark is now officially Formation Bio.

Introducing Formation Bio

There are several thousand known human diseases, yet we only have FDA-

approved treatments for about 500 of them

. Patients are desperately waiting for more. We are building the pharma company of the future designed to bring new treatments to patients faster than ever before. 